Shares of hVIVO plc (LON:HVO – Get Free Report) shot up 3.5% on Wednesday . The stock traded as high as GBX 20.60 ($0.26) and last traded at GBX 20.50 ($0.26). 1,418,431 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 3,544,421 shares. The stock had previously closed at GBX 19.80 ($0.25).
hVIVO Stock Performance
The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The stock has a market capitalization of £139.48 million, a P/E ratio of 660.00 and a beta of 0.97. The business has a fifty day moving average price of GBX 27.52 and a 200-day moving average price of GBX 27.95.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- What is a Bond Market Holiday? How to Invest and Trade
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Upcoming IPO Stock Lockup Period, Explained
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is a Dividend King?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
